Browse Studies — Arctuva

Phase 1

A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALV-100 in Participants With Overweight or Obesity With or Without Type 2 Diabetes

A Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants with or without Type 2 Diabetes

Overweight or Obese AdultsOverweight or Obese, Type 2 Diabetes

Estimated

~$10 – $8,750

Alveus Therapeutics, Inc.NCT07399678

Observational

Prevention of Weight Gain and Impaired Glucose Metabolism Post Kidney Transplantation: A Pilot and Feasibility Study

The goal of this clinical trial is to learn whether if it is feasible to implement a study of patients receiving kidney transplantation, to learn if these pati…

Kidney TransplantOverweight or Obese AdultsGlucose Control

Estimated

~$10 – $6,250

University of Kansas Medical CenterNCT06640179

Observational

Effects of Pistachio Snacking on Metabolic Flexibility in Healthy Overweight and Obese Adults

The purpose of this study is to evaluate the effects of pistachio snacking on metabolic flexibility (at rest, during exercise, and in post-exercise recovery) i…

Overweight (BMI > 25)Obese But Otherwise Healthy ParticipantsOverweight or Obese+4 more

Estimated

~$10 – $6,250

University of South CarolinaNCT07340125

Phase 1

A Phase 1, Double-Blind, Randomized, Ascending-Dose, Placebo-Controlled, Multiple-dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets Orally Administered in Non-diabetic Overweight or Obese Adult Subjects

This is a Phase 1, single-center, randomized, placebo-controlled, ascending dose study. The study will evaluate the pharmacokinetics (PK), pharmacodynamic (PD)…

Non-diabetic Overweight or Obese

Estimated

~$10 – $8,750

BrightGene Bio-Medical Technology Co., Ltd.NCT07166081